| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | 16 |
| Amoxicillin/Clavulanic acid | Sensitive | 8 |
| Cefepime | Sensitive | <=0.12 |
| Cefotaxime | Sensitive | 1 |
| Ceftazidime | Sensitive | 1 |
| Ceftriaxone | Sensitive | <=0.25 |
| Cefuroxime | Sensitive | 8 |
| Ciprofloxacin | Resistant | >=4 |
| Colistin | Intermediate | 1 |
| Ertapenem | Sensitive | <=0.12 |
| Fosfomycin | Sensitive | <=16 |
| Gentamicin | Resistant | >=16 |
| Imipenem | Sensitive | <=0.25 |
| Levofloxacin | Resistant | 128 |
| Meropenem | Sensitive | <=0.25 |
| Nitrofurantoin | Resistant | 128 |
| Piperacillin/Tazobactam | Sensitive | 16 |
| Tobramycin | Resistant | 64 |
| Trimethoprim/Sulfamethoxazole | Sensitive | <=0.5 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|
| oqxA | PCR |